Biotoxtech Co Ltd
KOSDAQ:086040
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pekat Group Bhd
KLSE:PEKAT
|
MY |
|
Geechs Inc
TSE:7060
|
JP |
Biotoxtech Co Ltd
Total Equity
Biotoxtech Co Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Biotoxtech Co Ltd
KOSDAQ:086040
|
Total Equity
₩42.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Total Equity
₩12.2T
|
CAGR 3-Years
11%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
A
|
ADM Korea Inc
KOSDAQ:187660
|
Total Equity
₩21.5B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Total Equity
₩146.3B
|
CAGR 3-Years
40%
|
CAGR 5-Years
14%
|
CAGR 10-Years
24%
|
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Total Equity
₩593.4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Total Equity
₩507.6B
|
CAGR 3-Years
32%
|
CAGR 5-Years
35%
|
CAGR 10-Years
28%
|
|
Biotoxtech Co Ltd
Glance View
Biotoxtech Co., Ltd. engages in the provision of non-clinical drug trials. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2007-09-21. The firm provides safety evaluation research, efficacy evaluation research and analysis research. Its safety evaluation research business provides general toxicity tests, local toxicity tests, reproductive and development tests, genotoxicity tests, immunotoxicity tests, carcinogenicity tests, safety pharmacology tests, ecotoxicology tests, histopathology tests and hematology tests. Its efficacy evaluation research business provides efficacy evaluation of medical supplies, health supplements and cosmetics. Its analysis research business provides pharmacokinetics (PK) tests and toxicokinetics (TK) tests services, as well as validation and bio analysis services. On March 13, 2013, the Company acquired a 60% stake in its new established subsidiary.
See Also
What is Biotoxtech Co Ltd's Total Equity?
Total Equity
42.1B
KRW
Based on the financial report for Sep 30, 2025, Biotoxtech Co Ltd's Total Equity amounts to 42.1B KRW.
What is Biotoxtech Co Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
6%
Over the last year, the Total Equity growth was -9%. The average annual Total Equity growth rates for Biotoxtech Co Ltd have been -2% over the past three years , 5% over the past five years , and 6% over the past ten years .
